Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
Journal: Cardiovascular drugs and therapy
Published: May 09, 2023
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.
Journal: JACC. Heart failure
Published: February 19, 2021
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Journal: Journal of the American College of Cardiology
Published: October 05, 2020
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
Journal: Cardiovascular drugs and therapy
Published: January 25, 2019
Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis.
Journal: Therapeutic advances in cardiovascular disease
Published: December 22, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026